BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23847189)

  • 1. BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.
    Boiocchi L; Lonardi S; Vermi W; Fisogni S; Facchetti F
    Blood; 2013 Jul; 122(2):296-7. PubMed ID: 23847189
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
    Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
    Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Minimal Bone Marrow involvement of Blastic Plasmacytoid Dendritic Cell Neoplastic Cells - CD303 immunostaining as a diagnostic tool.
    Ohe R; Aung NY; Shiono Y; Utsunomiya A; Kabasawa T; Tamazawa N; Tamura Y; Kato T; Yamada A; Hasegawa S; Aizawa K; Inokura K; Ito S; Toubai T; Kato Y; Tsunoda T; Onami K; Suzuki T; Ishizawa K; Yamakawa M
    J Clin Exp Hematop; 2018 Mar; 58(1):1-9. PubMed ID: 29415975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1c+ and CD303+ dendritic cells in peripheral blood, lymph nodes and tumor tissue of patients with non-small cell lung cancer.
    Tabarkiewicz J; Rybojad P; Jablonka A; Rolinski J
    Oncol Rep; 2008 Jan; 19(1):237-43. PubMed ID: 18097601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differentiation of new human CD303
    Zhong Q; Lu Y; Xu W; Rong Z; Chang X; Qin L; Chen X; Zhou F
    Int Immunopharmacol; 2021 Oct; 99():107983. PubMed ID: 34298400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes.
    Gerlini G; Di Gennaro P; Mariotti G; Urso C; Chiarugi A; Pimpinelli N; Borgognoni L
    J Invest Dermatol; 2010 Mar; 130(3):898-901. PubMed ID: 19829303
    [No Abstract]   [Full Text] [Related]  

  • 7. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid.
    Tsoumakidou M; Tzanakis N; Papadaki HA; Koutala H; Siafakas NM
    Immunol Cell Biol; 2006 Jun; 84(3):267-73. PubMed ID: 16509829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions.
    Woltman AM; de Fijter JW; Zuidwijk K; Vlug AG; Bajema IM; van der Kooij SW; van Ham V; van Kooten C
    Kidney Int; 2007 May; 71(10):1001-8. PubMed ID: 17361115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation.
    Chen YL; Gomes T; Hardman CS; Vieira Braga FA; Gutowska-Owsiak D; Salimi M; Gray N; Duncan DA; Reynolds G; Johnson D; Salio M; Cerundolo V; Barlow JL; McKenzie ANJ; Teichmann SA; Haniffa M; Ogg G
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31845972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human C-type lectin domain family 4, member C (CLEC4C/BDCA-2/CD303) is a receptor for asialo-galactosyl-oligosaccharides.
    Riboldi E; Daniele R; Parola C; Inforzato A; Arnold PL; Bosisio D; Fremont DH; Bastone A; Colonna M; Sozzani S
    J Biol Chem; 2011 Oct; 286(41):35329-35333. PubMed ID: 21880719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Mechanism for Binding of Galactose-terminated Glycans by the C-type Carbohydrate Recognition Domain in Blood Dendritic Cell Antigen 2.
    Jégouzo SA; Feinberg H; Dungarwalla T; Drickamer K; Weis WI; Taylor ME
    J Biol Chem; 2015 Jul; 290(27):16759-71. PubMed ID: 25995448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2.
    Röck J; Schneider E; Grün JR; Grützkau A; Küppers R; Schmitz J; Winkels G
    Eur J Immunol; 2007 Dec; 37(12):3564-75. PubMed ID: 18022864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of B7-H1 and B7-H4 co-stimulatory molecules on myeloid and plasmacytoid dendritic cells in pre-eclampsia and normal pregnancy.
    Darmochwal-Kolarz D; Kludka-Sternik M; Kolarz B; Chmielewski T; Tabarkiewicz J; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    J Reprod Immunol; 2013 Sep; 99(1-2):33-8. PubMed ID: 23773232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and maturation of skin dendritic cell subsets in two forms of cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.
    Schwingshackl P; Obermoser G; Nguyen VA; Fritsch P; Sepp N; Romani N
    Acta Derm Venereol; 2012 May; 92(3):269-75. PubMed ID: 22678564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls.
    Van Vré EA; Bosmans JM; Van Brussel I; Maris M; De Meyer GR; Van Schil PE; Vrints CJ; Bult H
    Pathology; 2011 Apr; 43(3):239-47. PubMed ID: 21436634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells in muscle lesions of sarcoidosis.
    Tateyama M; Fujihara K; Itoyama Y
    Hum Pathol; 2011 Mar; 42(3):340-6. PubMed ID: 21111453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
    Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
    Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome.
    Zuidwijk K; de Fijter JW; Mallat MJ; Eikmans M; van Groningen MC; Goemaere NN; Bajema IM; van Kooten C
    Kidney Int; 2012 Jan; 81(1):64-75. PubMed ID: 21866093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.
    Riboldi E; Daniele R; Cassatella MA; Sozzani S; Bosisio D
    Immunobiology; 2009; 214(9-10):868-76. PubMed ID: 19577819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.